A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Lyell Immunopharma, Inc.
St. Jude Children's Research Hospital
Gilead Sciences
Affiliated Hospital to Academy of Military Medical Sciences
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Gilead Sciences
Allogene Therapeutics
Allogene Therapeutics
Allogene Therapeutics
M.D. Anderson Cancer Center
Gilead Sciences
St. Jude Children's Research Hospital
Celgene
Chinese PLA General Hospital
University of Maryland, Baltimore
Affimed GmbH
Chinese PLA General Hospital
Dana-Farber Cancer Institute
University Health Network, Toronto
CARGO Therapeutics
Affiliated Hospital to Academy of Military Medical Sciences
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
M.D. Anderson Cancer Center
Gilead Sciences
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
University College, London
The First Affiliated Hospital of Soochow University
Shanghai Ming Ju Biotechnology Co., Ltd.
Precision BioSciences, Inc.
Keimyung University Dongsan Medical Center
Gilead Sciences
Therapeutic Advances in Childhood Leukemia Consortium
Lymphoma Study Association
University of Illinois at Chicago
M.D. Anderson Cancer Center
Peking University
Massachusetts General Hospital
University of Chicago
Samsung Medical Center
WiSP Wissenschaftlicher Service Pharma GmbH
Sun Yat-sen University
Gruppo Italiano Studio Linfomi